A Comparison of Esmolol and Remifentanil to Reduce Blood Loss

NCT01752959 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Deviation Septum Nasal

Interventions

DRUG: Remifentanil
DRUG: Esmolol

Sponsor

Diskapi Teaching and Research Hospital